PA Eyers
Use of a drug-resistant mutant of stress-activated protein kinase2a/p38 to validate the in vivo specificity of SE 203580
Eyers, PA; van den Ijssel, P; Quinlan, RA; Goedert, M; Cohen, P
Citation
Eyers, P., van den Ijssel, P., Quinlan, R., Goedert, M., & Cohen, P. (1999). Use of a drug-resistant mutant of stress-activated protein kinase2a/p38 to validate the in vivo specificity of SE 203580. FEBS Letters, 451(2), 191-196
| Journal Article Type | Article |
|---|---|
| Publication Date | 1999-05 |
| Journal | FEBS Letters |
| Print ISSN | 0014-5793 |
| Electronic ISSN | 1873-3468 |
| Publisher | Federation of European Biochemical Societies |
| Volume | 451 |
| Issue | 2 |
| Pages | 191-196 |
| Keywords | SAPK2; p38; SB203580; MAPKAP-K2; MSK1; CREBP38 MAP KINASE; AMINO-ACID SUBSTITUTION; HEAT-SHOCK PROTEINS;SUBSTRATE-SPECIFICITY; CELLULAR STRESSES; MAMMALIAN-CELLS; SAP KINASES;PHOSPHORYLATION; INHIBITORS; SB-203580 |
| Public URL | https://durham-repository.worktribe.com/output/1550182 |